Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: BioNTech, Vir Launch IPOs But Take US Offerings To Market At A Discount

Finance Watch

Related Content

Keeping Track: US FDA, Industry Roar Into Fourth Quarter With Bevy Of Regulatory Announcements

Oct 06 2019

Lannett Strikes Deal For Respirent’s US Advair Rival

Oct 01 2019

Deal Watch: Purdue Continues Move Away From Opioids With Alivio Deal

Jan 28 2019

$500m And Counting: Vir Puts Big Money To Work In Infectious Diseases

Oct 19 2017

OncoSec Pushes IL-12 Approach Forward In PD-1 Melanoma Failures

Feb 24 2017

Tough Going Forces Chinese Biotechs To Form Domestic Alliances

Feb 21 2019

Finance Watch: Scripps Research Models A New Way To Fund Translation

Feb 26 2019

VC Roundup: Infectious Disease Startup Snags $150m And Former Biogen CEO Scangos

Jan 08 2017

Tocagen On The Rocks With Phase III Brain Cancer Study Failure

Sep 12 2019

US FDA AdComm Win For Aimmune’s Palforzia Bodes Well For DBV’s Peanut Allergy Patch

Sep 19 2019

Finance Watch: Genmab Launches This Year's Biggest Biopharma IPO In The US

Jul 18 2019

BioNTech Fills Coffers With Extra $325m Via Series B Financing

Jul 09 2019

China's Innovent Biologics Emerges As Immuno-Oncology Competitor With Sintilimab Approval

Jan 02 2019

Trend Revising? Biotech IPOs Slow Sharply In HK While Shanghai's STAR Shines

Aug 21 2019

Finance Watch: Summer Slowdown Nears Its End With Strategic Shifts And IPO Hopes

Aug 30 2019

Strong Innovent IPO Restoring Faith In HK Biotech Listings?

Oct 31 2018

Innate Pharma's Expanded IO AstraZeneca Deal Jump-Starts US Ambitions

Oct 23 2018

Rigel Readies Tavalisse For Late-May Launch After FDA Approval

Apr 18 2018

Top Financings: 2018 Was A Remarkable Year For Biopharma Fundraising

Jan 09 2019

Asia Deal Watch: Innovent Picks Up Asian Rights To Three Clinical Cancer Candidates From Incyte

Dec 20 2018

Finance Watch: Summer Heat Extends To Biopharma IPOs With Nine In July, 45 This Year

Aug 01 2018

Dosing Woes For VBI Vaccines As Share Price Plummets On Hep B Study Results

Jun 19 2019

Related Companies

BioNTech SE

Vir Biotechnology, Inc.

Genmab A/S

Moderna, Inc.

Innate Pharma S.A.

Oyster Point Pharma, Inc.

Innovent Biologics, Inc.

HUTCHMED (China) Limited

Eli Lilly and Company

Heron Therapeutics, Inc.

DBV Technologies

Aimmune Therapeutics, Inc.

Lannett Company, Inc.

Constellation Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.

Medison Pharma Ltd.

Aclaris Therapeutics, Inc.

VBI Vaccines Inc.

OncoSec Medical Incorporated

Merck & Co., Inc.

Sorrento Therapeutics, Inc.

Plus Therapeutics, Inc.

Five Prime Therapeutics, Inc.

Tocagen, Inc.

Merrimack Pharmaceuticals, Inc.

Selvita S.A.

Additional Topics

Financing StartUps and SMEs Business Strategies Companies Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window